Health ❯ Healthcare ❯ Research

Therapeutics

Drug Development Neuronal Protection Regenerative Medicine Targeted Therapies Neuroinflammation Immunotherapy

Study Finds PU.1-Low, CD28-Positive Microglia Curb Alzheimer’s Damage

Peer-reviewed findings in Nature connect SPI1 genetics to a microglial mechanism with preclinical evidence.

Neuron-Microglia Signal Near Plaques Emerges as a Potential Alzheimer’s Target